A study of different dose levels of FluBHPVE6E7 or placebo in women infected with the virus Human Papilloma Type 16 (HPV 16).

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515535-30-00

Acronym

BS-02

Enrollment

Registered

2024-09-20

Start date

2023-06-22

Completion date

Unknown

Last updated

2025-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

precancers and cancers, Treatment of human papilloma virus (HPV) associated infections

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Slovakia

None listed

Source: EU CTIS · Data processed: Feb 4, 2026